On the basis of these findings, we concluded that high levels of Sp1 in malignant/stemlike GBM cells modulated the balance between prosurvival and prodeath signals, thereby protecting these cells against stress conditions and cancer therapies (Figure 8). This evidence concerns the gene SP1 and glioblastoma.